IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL

Reitinger C, Nimmerjahn F (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Journal for ImmunoTherapy of Cancer BioMed Central

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: A22-A22

Conference Proceedings Title: JOURNAL FOR IMMUNOTHERAPY OF CANCER

DOI: 10.1136/jitc-2021-ITOC8.41

Authors with CRIS profile

Carmen Reitinger Lehrstuhl für Genetik Falk Nimmerjahn Lehrstuhl für Genetik

How to cite

APA:

Reitinger, C., & Nimmerjahn, F. (2021). IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (pp. A22-A22). LONDON: BMJ PUBLISHING GROUP.

MLA:

Reitinger, Carmen, and Falk Nimmerjahn. "IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL." Proceedings of the JOURNAL FOR IMMUNOTHERAPY OF CANCER LONDON: BMJ PUBLISHING GROUP, 2021. A22-A22.

BibTeX: Download